Attention deficit and hyperactivity disorder
Conditions
Interventions
Acute remission group:None
Non-remission group:None
Sponsors
Peking University Sixth Hospital
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Have used methylphenidate hydrochloride sustained-release treatment and systematically titrated to the optimal dose, and the total treatment time is not less than 6 months; 2.The current age is over 12 years old; 3.Contact the patient or guardian to agree to a follow-up interview.
Exclusion criteria
Exclusion criteria: Individuals with major neurological disorders, a diagnosis of schizophrenia, mental retardation or other brain disorders from January 2010–December 2019.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychiatric status and functional outcomes of long-term treatment in patients with attention deficit hyperactivity disorder; | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors influencing long-term psychiatric status and functional outcomes;The relationship between attention-deficit hyperactivity disorder symptom relief and social/executive function;Long-term application of methylphenidate hydrochloride sustained release in patients with attention deficit hyperactivity disorder; | — |
Countries
China
Contacts
Public ContactYang Li
Peking University Sixth Hospital
Outcome results
None listed